News on: cortisol, CRP, Psilocybin

Latest news: A new study has shown that the anti-depressant effects of psilocybin may be partly due to its anti-inflammatory effects within the brain. This interesting study offers us further insight into how psilocybin can effectively alleviate symptoms of depression by acting on various pathways in the brain that regulate inflammation. Although the exact mechanisms of action are not yet fully understood, this study offers a promising avenue for future exploration and development of psilocybin-based treatments for depression. It is crucial that we continue to explore and understand the ways in which psilocybin and other naturally occurring substances can contribute to mental health and well-being, while continuing to look for new and innovative ways to address the increasing prevalence of mental health disorders worldwide.